Graticule Asia Macro Advisors LLC Eli Lilly & CO Transaction History

Graticule Asia Macro Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $3.14 Million - $4.06 Million	-17,390 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $2.86 Million - $3.7 Million	17,390 New	17,390 $3.25 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $921,330 - $1.03 Million	-8,700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $480,816 - $600,936	5,600 Added 180.65%	8,700 $934,000
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $15,140 - $17,376	200 Added 6.9%	3,100 $265,000

Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $215,208 - $254,039	2,900 New	2,900 $224,000

3,725

738M

7.09M

7.24M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Graticule Asia Macro Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Graticule Asia Macro Advisors LLC with notifications on news.